Minerva Neurosciences, Inc.
USD4.37
+0.26 (+6.33%)
CEO
Remy Luthringer
IPO Date
2014-07-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.12
Prev. Close
$4.11
Day Low
$4.08
Day High
$4.45
52W Low
$1.57
52W High
$12.46
Market Cap
$0.03B
Volume
3.87M
| 1,690,700 |
| $4.68 |
| 5 Jun 2026 | Laghrissi-Thode Fouzia | director | A-Award | Acquired | 50,000 | $4.68 |
| 5 Jun 2026 | Kupfer David | director | A-Award | Acquired | 50,000 | $4.68 |
| 5 Jun 2026 | Kaul Inderjit | director | A-Award | Acquired | 50,000 | $4.68 |
| 5 Jun 2026 | VAN HEEK G JAN | director | A-Award | Acquired | 50,000 | $4.68 |
| 5 Jun 2026 | HASLER HANS PETER | director | A-Award | Acquired | 50,000 | $4.68 |
| 22 Apr 2026 | O'Connor James Joseph | Chief Business Officer and GC | A-Award | Acquired | 350,800 | $6.97 |
| 22 Apr 2026 | O'Connor James Joseph | — | Disposed | 0 | $0.00 |
| 1 Apr 2026 | Kaul Inderjit | director | A-Award | Acquired | 12,169 | $6.03 |